hims glp-1 pills & Hers stock drops 30% after Novo Nordisk terminates deal Hims & Hers copies Novo

Tirzepatide also beat weekly semaglutide by 3.2% and liraglutide by a huge 17.2%

Experimental study on physical exercise in diabetes: Pathophysiology and therapeutic effects

Existing GLP-1 Evidence While the dream of a patch remains theoretical, the evidence for injectable and oral GLP-1 drugs is remarkably robust

For example, Rybelsus (semaglutide tablets), the first oral GLP-1 approved for type 2 diabetes, has demonstrated meaningful weight loss in clinical studies, although it currently requires strict administration guidelines (empty stomach, limited fluid intake before and after dosing)

Then Eli Lilly has to go ahead and drop a dang bombshell and interrupt my plans

Stefan Macher: declares no conflict of interest relevant to this study